“Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor filings reveal that pot poses a direct threat to their plans to cash in on a synthetic cannabis product they have developed.”
Related Posts
Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study (2013)
- WOCredentials
- September 19, 2016
- 0
“a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn’s disease, compared with placebo, without side effects.” Naftali, T., […]
Cannabinoid improves survival rates of mice with pancreatic cancer
- WOCredentials
- July 31, 2018
- 0
“Mice with pancreatic cancer that were treated with a naturally occurring constituent of medicinal cannabis alongside chemotherapy, survived almost three times longer than those treated with chemotherapy alone, a new […]
Hallucinogenic drug psilocybin eases existential anxiety in people with life-threatening cancer
- WOCredentials
- December 1, 2016
- 0
“The Johns Hopkins group reported that psilocybin decreased clinician- and patient-rated depressed mood, anxiety and death anxiety, and increased quality of life, life meaning and optimism. Six months after the […]